LEO Pharma’s Post

The patient voice was central to NET research priorities at an international insightful conference on June 6th, 2024, in Bari, Italy on “The Biology, Diagnosis and Treatment of NETs: Current Understanding and Research Priorities”.    Dr. Mauro Cives, Senior Assistant Professor of Medical Oncology at the Department of Interdisciplinary Medicine of the University of Bari “Aldo Moro”, noted: “I think that it is crucial to fill the gap in the current system between basic researchers and basic research and patients. This is our key unmet need we have in our field; we need frequent communication between patients and researchers and we need to avoid doing research that cannot have an impact on patients.”   The conference day wrapped up with an engaged discussion on patient needs and priorities, which again asserted the instrumental role of active patient input in research design. INCA Executive Director Teodora Kolarova and NET Italy ETS President Maria Luisa Draghetti and NET Italy ETS Vice-President Simona Barbi had the privilege of voicing the patient expectations and challenges, as well as highlighting the continued global and local effort to raise awareness and improve understanding of neuroendocrine tumors both among the general public and the medical profession.  Luciano Licciardello ✅ Find out more: https://lnkd.in/d995X2vG   #LetsTalkAboutNETs #NeuroendocrineCancer #NETResearch

☢ Theranostics ☢ ☢ The innovative approach that merges therapy and diagnostics, is revolutionizing medicine. By tailoring medical treatment to individual patients, theranostics improves outcomes and minimizes side effects. This approach holds promise in various medical areas, from oncology and neurology to cardiology and infectious diseases. ☢ The ongoing 7th Theranostics World Congress in Santiago, Chile, is a testament to the potential of this approach. Organized by Dr. Horacio Amaral, Dr. Richard Baum, Prof. Dr. Frank Rösch, and Dr. Vasko Kramer, this conference has been one of the best I ever attended. ☢ Now, I'm excited to announce the foundation of Berking Theranostics. This dedicated entity is focused on developing single-chain Nanoantibodies from Alpacas to fight tumors and it's based in Hamburg. ☢ Berking Theranostics is now open to collaboration with stakeholders in the theranostics world. ☢ Join us in exploring the possibilities of theranostics and its potential to transform patient care. #Theranostics #MedicalInnovation #PatientCare #Collaboration #hamburg #Chile #prochile #Alpacas #Novartis #3BP Camilo Andrés Anabalón Alamos Klaus Hübner Anna-Lena Kaiser Markus Schreyer Christian Lührs Robin Prosch TetraKit Technologies Matthias Herth Alice Viana Sunao Fujioka Novartis 3B Pharmaceuticals GmbH Siemens Healthineers Philipp Baaske Konstantin Matentzoglu Melanie Mengerink

 Advancing Precision Medicine Annual Conference and Exhibition in Philadelphia, Pennsylvania. This event will consist of three immersive tracks, each crafted to explore the multifaceted dimensions of precision medicine. Delve into Precision Oncology, where groundbreaking advancements are reshaping the landscape of cancer diagnosis and treatment. Traverse the boundaries of Precision Medicine Outside of Oncology, as we probe into the intricate interplay of genetics, lifestyle, and environment across a spectrum of diseases and conditions including rare disease, cardiology, ophthalmology, and neurodegenerative disease. Immerse yourself in AI for Precision Medicine, where cutting-edge technologies are revolutionizing diagnostics, therapeutics, and patient care. Additionally, explore the emerging frontiers of Spatial Biology and Mult-Omics, where integrated approaches are unraveling the complexities of biological systems with unprecedented depth and precision.https://https://lnkd.in/gBM424UK

Digital Artery Volume Index (#DAVIX): 10 years in the making, from academic bench to the highlight of the year by The Lancet. We are paving a way for DAVIX to help with patient stratification and drug efficacy assessment in #clinicaltrials with #DYNAMIKA and IAG, IMAGE ANALYSIS GROUP. #scleroderma #vascular #disease #innovation #drugdevelopment

📢 Excited to share my latest publication: "Abbreviated MRI for Hepatocellular Carcinoma Surveillance – A Systematic Review and Meta-analysis"! 🔍 Conducting a systematic review and meta-analysis has been an enlightening journey, offering insights into the efficacy of abbreviated MRI in HCC surveillance. This publication represents a significant milestone in my academic career and adds valuable evidence to the field. 📚 Systematic reviews and meta-analyses are the pinnacle of evidence-based medicine, providing comprehensive insights into existing research. I'm proud to contribute to the scientific community's understanding of HCC surveillance methods. 🔬 Our findings shed light on the effectiveness and potential implications of abbreviated MRI in clinical practice, offering clinicians and researchers valuable information for decision-making and further investigation. 📄 For those interested in delving deeper, you can access the full publication here: https://lnkd.in/gGDCQjHH I'm grateful to my colleagues and mentors for their support throughout this research endeavor. Looking forward to continued collaboration and exploration in the field of HCC surveillance! #Research #HepatocellularCarcinoma #MRI #SystematicReview #MetaAnalysis #EvidenceBasedMedicine #AcademicPublication

Professor Francesco Del Galdo (Lead for Scleroderma Program in Leeds, UK and IAG, IMAGE ANALYSIS GROUP Scientific Advisory Board member) will be presenting the latest results on the use DAVIX (Digital Artery Volume Index) a MRI biomarker in assessment of vascular changes in scleroderma during the 8th World Congress on Systemic Sclerosis. 14:00-15:30 Forum Hall / SESSION 11 - TOP OF SSc SCIENCE - BEST FROM JOURNALS • Lancet Rheumatology - The Lancet MRI Digital Artery Volume Index (DAVIX) as a surrogate outcome measure of digital ulcer disease in patients with SSc: a prospective cohort study F Del Galdo et al (UK) An opportunity to not be missed! #scleroderma #rarediseases #drugresearch #mri #medicalimaging #drugdevelopment

Ultrasound Guided Synovial Biopsies can be easily performed by an ultrasound-trained rheumatologist and can help advance research to learn more about various arthritides and how they can be optimally treated. Check out the the latest Best Practices in Rheumatology article on UGSBy by our USSONAR UGSBy faculty https://lnkd.in/dnRUrW7U Diane Horowitz Arthur Mandelin, MD, PhD, FACR, RhMSUS, RMSK #AmiBenArtziMDRhMSUS #DarrenTabechianMD #precisionmedicine #spatialtranscriptomics #rheumatoidarthritis #ultrasound #POCUS #rheumatology

📢 We are proud to announce the publication of our latest study in the Journal of Rheumatology and Therapy ⬇️     ✅ In this post-market observational study, the team has investigated the long-term efficacy of a single intra-articular injection of carboxymethyl-chitosan (CM-chitosan), a new product class for the symptomatic treatment of knee osteoarthritis. ✅ This study aimed to corroborate the effectiveness of the innovation in real-world clinical setting over a 9-month period, focusing on a diverse range of patients with knee OA, particularly those not responding to conventional therapies. 🙏🏻 A special thank you to Dr. Nils Lynen, Dr. Christoph Eichhorn, and all the investigators and authors involved in this work. We're excited to discuss these findings further at the upcoming ESSKA and EFORT congresses: 📅 ESSKA: 08-10 May, Milan – Poster presentation 📅 EFORT: 22-24 May, Hamburg - Oral Session presentation (Wednesday 22 May – 9am) For the full details of our study, click here ➡️ https://lnkd.in/ehNiY5gR Any questions? 📧contact@kiomedpharma.com     #Osteoarthritis #Innovation #ClinicalResearch #Rheumatology #CMChitosan

Are you looking for opportunities to share your mitochondrial research on a global platform? Our 2024 Mitochondrial Medicine - Therapeutic Developments conference is a key research meeting to add to your diary. 📅 Conference dates: 18-20 March 2024 We are accepting abstract submissions until 23 January 2024, to be considered for a short talk or poster presentation. ⏰ Build your professional profile at the forefront of the mitochondrial medicine research community. #MitoMed24 Your contributions could help bridge the gaps between research and clinical practice, and support the acceleration of novel and effective treatments. Endorsed by the European Society for Mitochondrial Research and Medicine, the Mitochondrial Medicine Society and the European Reference Network – Neuromuscular Diseases (EURO-NMD), this meeting is your chance to gain feedback on your current research project(s), from leading experts in the field. 📎 Click this link to find out more about the conference:  https://bit.ly/45xMCIX #Mitochondria #MitochondrialDisease #MitochondrialMedicine #AcademicChatter #PhDchat #ScientificConferences #MitochondrialResearch

The 7th IPF Summit is only 3 weeks away and with only 13 passes remaining, are you and your team registered? Registration options and full event guide can be accessed here through the website: https://ter.li/bq55ve Join 80+ biopharma attending organisations and 150+ individuals at this year's summit to harness emerging biological understanding, employ novel dynamic preclinical models (organoids, lung-on-a-chip, and more) to cement translational confidence, and capture imaging endpoints to develop and advance the next generation of IPF drugs Expert speakers include: Fernando Martinez, Chief of Pulmonary & Critical Care, Weill Cornell Medicine Gisli Jenkins, NIHR Research Professor & Margaret Turner Warwick Chair of Thoracic Medicine, Imperial College London Joyce Lee, Professor, University of Colorado Denver Naftali Kaminski, Chief of Pulmonary, Critical Care & Sleep Medicine, Yale School of Medicine Toby Maher, Professor of Critical Care Medicine, University of Southern California Andrew Thorley, Director & Group Leader, Genentech Caroline Owen, MD, PhD, FRCP, Executive Director, Medical Early Clinical Development, Respiratory & Immunology, Astrazeneca Eric White, MD, MS, FCCP, ATSF, Senior Clinical Program Lead, Boehringer Ingelheim Henrik Landgren, Director, Scientific Precision Medicine, Immunology & Fibrosis, AbbVie Steven Greenberg, Vice President, Disease Area Head, Pulmonology, Bristol Myers Squibb Sudha Visvanathan, Vice President & Head of Global TMCP & TA Inflammation, Boehringer Ingelheim To see the full speaker faculty, view the agenda here: https://ter.li/bq55ve Looking forward to seeing the pulmonary fibrosis community once again in Boston! Make sure to get one of those 13 passes - once they're gone, they're gone! #IPF #Pulmonaryfibrosis #idiopathicpulmonaryfibrosis #drugdevelopment #ILD #interstitiallungdisease #inhalation #respiratory #Boston